Clinical Trials Logo

Bladder Carcinoma Stage IV clinical trials

View clinical trials related to Bladder Carcinoma Stage IV.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03159585 Completed - Solid Tumor Clinical Trials

To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors

Start date: April 14, 2017
Phase: Phase 1
Study type: Interventional

The main purpose of this trial is to investigate the safety and tolerability of TAEST16001(TCR Affinity Enhancing Specific T cell Therapy)in the multi-line treatment failed advanced solid tumors except non small cell lung cancer,including liver cancer,gastric cancer,esophageal cancer,bone and soft tissue tumors,breast cancer, bladder carcinoma,prostate carcinoma,thyroid cancer, ovarian cancer and so on. The patients must meet the two criteria: human leukocyte antigens (HLA)-A*0201+ and NY-ESO-1 positive cells≥25% by immunohistochemistry.